Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Factor VIII mutation and desmopressin-responsiveness in 62 patients with mild haemophilia A.

Haemophilia : the official journal of the World Federation of Hemophilia - 1 Sept 2013

Nance D, Fletcher S N, Bolgiano D C, Thompson A R, Josephson N C, Konkle B A

Abstract excerpt

Utilization of the synthetic vasopressin analogue (1-deamino-8-D-arginine-vasopressin, DDAVP) in treatment of mild haemophilia A (MHA, specific clotting factor VIII activity level 0.05-0.4 IU mL(-1) ) is convenient and effective for many but not all patients. Genetic testing for patients with MHA is increasingly recognized as providing valuable information for patient care beyond informing reproductive decisions,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blood Coagulation and Thrombosis Mechanisms
Share to Coagulation, Bradykinin, Polyphosphates, and Angioedema

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Deamino Arginine Vasopressin

Share to Factor VIII

Share to Hemophilia A

Share to Hemophilia Treatment and Research

Share to Mutation

Source

Identifiers

PMID: 23711294
DOI: 10.1111/hae.12173

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Factor VIII mutation and desmopressin-responsiveness in 62 patients with mild haemophilia A.PMID 23711294Read ↗

Response to desmopressin is influenced by the genotype and phenotype in type 1 von Willebrand disease (VWD): results from the European Study MCMDM-1VWD.Semantic proximity Read ↗

Molecular and phenotypic determinants of the response to desmopressin in adult patients with mild hemophilia A.Semantic proximity Read ↗

DDAVP responsiveness in children with mild or moderate haemophilia A correlates with age, endogenous FVIII:C level and with haemophilic genotype.Semantic proximity Read ↗

Genotype-Dependent Response to Desmopressin in Hemophilia A and Proposal of a Predictive Response Score.Semantic proximity Read ↗

Response to desmopressin is strongly dependent on F8 gene mutation type in mild and moderate haemophilia A.Semantic proximity Read ↗

Site and type of mutations in the factor VIII gene in patients and carriers of haemophilia A.Semantic proximity Read ↗

Biologic response to desmopressin in patients with severe type 1 and type 2 von Willebrand disease: results of a multicenter European study.Semantic proximity Read ↗

Desmopressin in moderate hemophilia A patients: a treatment worth considering.Semantic proximity Read ↗

Inhibitors to Factor VIII in a Family with Mild Hemophilia: Molecular Characterization and Response to Factor VIII and DesmopressinSemantic proximity Read ↗

Pregnancy and delivery in women with von Willebrand's disease and different von Willebrand factor mutations.Semantic proximity Read ↗

Functional variation in the arginine vasopressin 2 receptor as a modifier of human plasma von Willebrand factor levels.Semantic proximity Read ↗

Biological effect of desmopressin in eight patients with type 2N ('Normandy') von Willebrand disease. Collaborative Group.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.